Janux Therapeutics Inc (JANX) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

JANX rapporto: 69%

100%

JANX supera 9 di 13 ultime stime

Data del prossimo reportNov 5, 2024

Stimato per Q3 24:$-0.35

Cambiamenti implicati per il Q2 24:+218.18%

Cambiamenti implicati per il Q3 23:+40.00%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 7, 2024	$-0.11 / $-0.32	$0.21 / 65.63%
Q1 24	May 7, 2024	$-0.3 / $-0.35	$0.05 / 14.29%
Q4 23	Mar 8, 2024	$-0.25 / $-0.37	$0.12 / 32.43%
Q3 23	Nov 7, 2023	$-0.25 / $-0.46	$0.21 / 45.65%
Q2 23	Aug 8, 2023	$-0.42 / $-0.52	$0.1 / 19.23%
Q1 23	May 9, 2023	$-0.42 / $-0.49	$0.07 / 14.29%
Q4 22	Mar 10, 2023	$-0.39 / $-0.45	$0.06 / 13.33%
Q3 22	Nov 10, 2022	$-0.4 / $-0.51	$0.11 / 21.57%

Fornitori di Dati: Xignite Logo